18 studies on Kpv curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
These findings highlight the significant potential of alpha-MSH peptides, particularly potent analogs like NDP-MSH, as a novel class of antimicrobial agents with a dual mechanism of action: direct bacterial killing an…
This research highlights the significant potential of alpha-MSH peptides as novel therapeutic agents for HIV-1 infection, particularly given their ability to modulate inflammation and directly suppress viral activity.…
This comprehensive synthesis underscores the significant therapeutic potential of alpha-MSH and its analogues for treating a wide array of inflammatory and autoimmune diseases, including conditions like psoriasis, rhe…
This research significantly advances our understanding of how alpha-MSH, KPV, and ACTH interact with human keratinocytes at a molecular level. Unraveling these specific signaling pathways provides a critical foundatio…
This research identifies [Ac-CKPV]2 as a highly promising candidate for the development of new therapies for fungal infections, particularly those caused by drug-resistant Candida strains which are difficult to treat.…
This review underscores the significant therapeutic potential of alpha-MSH related peptides as a novel class of drugs for treating chronic inflammatory and autoimmune diseases. Their multifaceted mechanism of action, …
This research highlights KPV as a promising therapeutic agent for intestinal inflammatory diseases due to its ability to be actively absorbed and exert potent anti-inflammatory effects. Its dual action of suppressing …
This study provides compelling evidence that the melanocortin-derived tripeptide KPV possesses significant anti-inflammatory and tissue-protective properties in preclinical models of IBD. Its ability to reduce multipl…
This research significantly broadens our understanding of α-MSH's complex anti-inflammatory mechanisms, indicating that its therapeutic potential extends beyond the well-characterized pharmacophore and melanocortin re…
This study reveals a novel immunomodulatory role for α-MSH in directly suppressing basophil activity, a critical component of allergic and inflammatory diseases. The significant reduction in histamine and leukotriene …
This research highlights PepT1 as a critical driver in the pathogenesis of colitis-associated cancer, suggesting it could be a novel diagnostic biomarker and a promising therapeutic target. The significant anti-tumor …
This study presents a highly promising and effective targeted oral delivery system for KPV, a potent anti-inflammatory tripeptide, directly to the inflamed colon. The innovative use of hyaluronic acid-functionalized n…
This research introduces a promising new method for modifying peptides to enhance their stability, which could significantly extend their half-life in the body and reduce the required dosing frequency for therapeutic …
This study highlights the significant potential of advanced drug delivery systems to substantially enhance the therapeutic efficacy of existing peptides like KPV for chronic inflammatory conditions. By improving both …
This study presents a highly promising and innovative therapeutic strategy for Ulcerative Colitis by directly targeting mucosal barrier dysfunction. The temperature-sensitive nature of the hydrogel allows for easy adm…
This comprehensive review highlights the significant therapeutic potential of tripeptides as a novel class of agents for treating chronic wounds and skin injuries. Their multi-faceted mechanisms of action, including a…